top of page

Topic

BRCA2 Mutation

2 Podcasts on BackTable

Hear how experienced physicians manage BRCA2 Mutation on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Exploring PARP Inhibitor Combinations in Prostate Cancer
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 71  •  07 Jul 2026

Exploring PARP Inhibitor Combinations in Prostate Cancer

With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for advanced prostate cancer? In this episode of BackTable Urology, Dr. Alan Tan is joined by Dr. Rana McKay and Dr. Emmanuel Antonarakis to discuss how evolving evidence, patient selection, timing, toxicity, and genetic testing are shaping the use of PARP inhibitor combinations in clinical practice.

This podcast is supported by an educational grant from Pfizer.

More on BRCA2 Mutation

Loading recent podcasts…

Tumor Board

Tumor Board # 71

Jul 6, 2026

with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan

Exploring PARP Inhibitor Combinations in Prostate Cancer

With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...

Urology

Urology # 79

Feb 7, 2023

with Dr. Todd Morgan, Dr. Aditya Bagrodia

Germline Testing in Prostate Cancer: Who, When, and How

In this episode of BackTable Urology, Dr. Aditya Bagrodia interviews Dr. Todd Morgan, chief of urologic oncology at the...

1,600+ listens

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page